← All trials
NCT06765356
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 30, 2025
- Primary completion
- Mar 30, 2027
- Completion date
- Mar 30, 2027
- First posted
- Jan 9, 2025
- Last posted
- Jan 9, 2025
- Enrollment
- 275
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Icahn School of Medicine at Mount SinaiLead sponsor
- Boston Scientific CorporationCollaborator
- Icahn School of Medicine at Mount SinaiSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.